OBiO Technology (SHG: 688238)

OBiO Technology is a corporation based in Shanghai, China. Established in 2013, the company is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The assets are managed by the executive management team.